Oncology & Cancer

A potential new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert ...

Oncology & Cancer

Better survival among women after lung cancer surgery

There are known differences in the survival rates of women and men with lung cancer. Researchers at Karolinska Institutet set out to investigate potential reasons behind this disparity, such as the presence of other underlying ...

page 1 from 3